The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value
Open accessAbstract
(See the Brief report by Tang Xiao et al on pages 2249–51.) To prevent the spread of coronavirus disease 2019 (COVID-19), it is important to identify and isolate people who are infectious. It is especially important to ensure that those with a high viral load are isolated and not able to transmit to others. Currently, diagnosis, screening, and surveillance depend on a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcriptase–quantitative polymerase chain reaction (RT-qPCR) test, and results are generally reported to the ordering physician as positive or negative. However, the test does provide a measure of the viral load in the sample, in what is called the cycle threshold (Ct) value. We suggest that reporting this Ct value, or a calculated viral load, can aid in interpretation and clinical decisions. We discuss the merits of PCR tests and other approaches, such as time-since-symptom-resolution-based approaches for removing individuals from isolation. In this issue of Clinical Infectious Diseases, Xiao et al [1] report that SARS-CoV-2 RT-qPCR results can remain positive up to 5 weeks after onset of symptoms. The authors studied RT-qPCR results from 56 hospitalized patients with mild to moderate COVID-19 disease. Each patient received 4 to 7 tests over several weeks after symptom onset. The percentage of positive results declined from 100% in week 1 to 89.3%, 66.1%, 32.1%, 5.4%, and 0% in weeks 2, 3, 4, 5, and 6, respectively. The median time from symptom onset to negative testing was 24 days. Prolonged positive test results were associated with older age and comorbid diabetes or hypertension. Additionally, there were 4 patients with 2 consecutive negative test results who later tested positive again. A limitation is that the test results did not report Ct values, which would have provided valuable information about the amount of viral RNA in the samples, particularly important later in the course of infection. Other case series and our own experience also suggest that patients with 2 consecutive negative tests and resolved symptoms can subsequently test positive [2, 3]. Xiao et al conclude that longer periods of follow-up and repeat testing are necessary to limit viral spread. The Centers for Disease Control and Prevention (CDC) suggests 1 of 2 approaches for discontinuing isolation, one based on time since symptom onset and resolution and the other centered on 2 negative tests at least 24 hours apart [4]. Generally no longer transmitting virus upon 10 days after symptom onset and 3 days after symptom resolution. This approach is test-sparing and is particularly useful when resources are scarce or in the outpatient setting where repeat testing is onerous. When testing is available, decisions to lift isolation rely heavily on negative PCR tests to define a patient as no longer infectious. However, this may not be optimal because it assumes a positive PCR test is intended to mean infectivity. Closer examination of what the test results mean clinically, particularly when results are from RNA quantities near the lower limit of detection of the assay, could help guide clinical and public health strategies. The SARS-CoV-2 RT-qPCR test provides real-time quantification by first reverse transcribing SARS-CoV-2 RNA into DNA (RT step), and then performing qPCR, during which a fluorescence signal increases proportionally to the amount of amplified nucleic acid, enabling accurate quantitation of the RNA in the sample. If the fluorescence reaches a specified threshold within a certain number of PCR cycles (Ct value), the sample is considered a positive result. The Ct value is inversely related to the viral load and every ~3.3 increase in the Ct value reflects a 10-fold reduction in starting material. Many qPCR assays involve a Ct cutoff of 40 to consider the test positive, allowing detection of very few starting RNA molecules. This high sensitivity for viral RNA can be helpful for initial diagnosis. However, reporting as a binary positive or negative result removes useful information that could inform clinical decision making. Following complete resolution of symptoms, people can have prolonged positive SARS-CoV-2 RT-PCR test results, potentially for weeks, as Xiao et al report. At these late time points, the Ct value is often very high, representing the presence of very low copies of viral RNA [5–8]. In these cases, where viral RNA copies in the sample may be fewer than 100, results are reported to the clinician simply as positive. This leaves the clinician with little choice but to interpret the results no differently than for a sample from someone who is floridly positive and where RNA copies routinely reach 100 million or more. A positive RT-qPCR result may not necessarily mean the person is still infectious or that he or she still has any meaningful disease. First, the RNA could be from nonviable or killed virus. Live virus is often isolable only during the first week of symptoms but not af
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,247
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Young, B. E., Ong, S. W. X., Kalimuddin, S., Low, J. G., Tan, S. Y., Loh, J., Ng, O.-T., Marimuthu, K., Ang, L. W., Mak, T. M., et al. (2020) · JAMA · doi:10.1001/jama.2020.3204 · Cited by 2,059
Positive RT-PCR test results in patients recovered from COVID-19
Lan, L., Xu, D., Ye, G., Xia, C., Wang, S., Li, Y., & Xu, H. (2020) · JAMA · doi:10.1001/jama.2020.2783 · Cited by 1,251
Cheng, H.-Y., Jian, S.-W., Liu, D.-P., Ng, T.-C., Huang, W.-T., Lin, H.-H., & for the Taiwan COVID-19 Outbreak Investigation Team (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.2020 · Cited by 860
Xu, K., Chen, Y., Yuan, J., Yi, P., Ding, C., Wu, W., Li, Y., Ni, Q., Zou, R., Li, X., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa351 · Cited by 501
The COVID-19 Investigation Team (2020) · Nature Medicine · doi:10.1038/s41591-020-0877-5 · Cited by 405
Profile of RT-PCR for SARS-CoV-2: A Preliminary Study From 56 COVID-19 Patients
Xiao, A. T., Tong, Y. X., & Zhang, S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa460 · Cited by 232
Cited by
A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19
Rao, S. N., Manissero, D., Steele, V. R., & Pareja, J. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00324-3 · Cited by 398
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
Kissler, S. M., Fauver, J. R., Mack, C., Tai, C. G., Breban, M. I., Watkins, A. E., Samant, R. M., Anderson, D. J., Metti, J., Khullar, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2102507 · Cited by 335
Alexandersen, S., Chamings, A., & Bhatta, T. R. (2020) · Nature Communications · doi:10.1038/s41467-020-19883-7 · Cited by 305
Viral Cultures for Coronavirus Disease 2019 Infectivity Assessment: A Systematic Review
Jefferson, T., Spencer, E. A., Brassey, J., & Heneghan, C. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1764 · Cited by 280
Metadata
- Authors
- Tom, M. R., & Mina, M. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-21
- Volume
- 71
- Issue
- 16
- Pages
- 2252-2254
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3027223127
- Cited by
- 373
- References
- 9
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.